Donal CPA - HUGE Old Chief Officer

HUGEDelisted Stock  USD 0.09  0  4.56%   

Executive

Donal CPA is Chief Officer of HUGE Old
Age 47
Phone416 854 8884
Webhttps://www.fsdpharma.com

HUGE Old Management Efficiency

The company has return on total asset (ROA) of (0.3374) % which means that it has lost $0.3374 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6403) %, meaning that it created substantial loss on money invested by shareholders. HUGE Old's management efficiency ratios could be used to measure how well HUGE Old manages its routine affairs as well as how well it operates its assets and liabilities.
HUGE Old currently holds 337.46 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. HUGE Old has a current ratio of 3.9, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about HUGE Old's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 6 records

EXECUTIVE Age

Samantha WiddicombeBiofrontera
N/A
Daniel JDBiofrontera
N/A
Constantin FestMERCK Kommanditgesellschaft auf
46
Jon MBABiofrontera
N/A
Alycia TorresBiofrontera
N/A
Kai BeckmannMERCK Kommanditgesellschaft auf
58
FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 10 people. HUGE Old (HUGE) is traded on NASDAQ Exchange in USA and employs 10 people.

Management Performance

HUGE Old Leadership Team

Elected by the shareholders, the HUGE Old's board of directors comprises two types of representatives: HUGE Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HUGE. The board's role is to monitor HUGE Old's management team and ensure that shareholders' interests are well served. HUGE Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HUGE Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lakshmi Kotra, Chief Inc
Kevin Cassidy, Vice QualityLucid
Donal CPA, Chief Officer
Zeeshan Saeed, President Director
Dr BPHARM, CEO Director
Maryann Adesso, Corporate Secretary
Nathan CPA, Chief Officer
Andrzej MD, Vice Lucid
Anthony Durkacz, Co-Chairman of the Board
Randell Mack, President BioSciences

HUGE Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is HUGE Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Consideration for investing in HUGE Stock

If you are still planning to invest in HUGE Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the HUGE Old's history and understand the potential risks before investing.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
CEOs Directory
Screen CEOs from public companies around the world
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Fundamental Analysis
View fundamental data based on most recent published financial statements
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments